MARLBOROUGH, Mass.--(BUSINESS WIRE)-- Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, today announced that it signed a definitive agreement to acquire Endomagnetics Ltd (Endomag®), a ...

Hologic, Inc. HOLX announced that it has completed the previously announced acquisition of Endomagnetics Limited (Endomag), a UK-based developer of breast cancer surgery technologies, for ...

Hologic, a Marlborough-based medical device manufacturer, is expanding its product catalog through the planned $310-million acquisition of Endomagnetics, a breast cancer surgery technology developer.

Hologic plans to acquire Endomagnetics, which makes technology for breast cancer surgery, for about $310 million. Cambridge, U.K.-based Endomagnetics develops and sells technologies to mark tissue ...

MARLBOROUGH, Mass. – Hologic, Inc. (NASDAQ:HOLX), a prominent company in women's health, has confirmed the signing of a definitive agreement to acquire Endomagnetics Ltd, known as Endomag, for ...